Karen Guarco, MBA Finance
About Karen Guarco, MBA Finance
Karen Guarco is the SVP of Finance and Research Operations with over 20 years of experience in drug discovery and finance, having held leadership roles at Alexion Pharmaceuticals and Vion Pharmaceuticals.
Professional Background of Karen Guarco
Karen Guarco has accumulated over 20 years of experience in drug discovery and finance. Her career spans various roles, from research to high-level financial management, showcasing her versatility and deep expertise in the pharmaceutical sector. Karen's career began at Bayer Healthcare in Research Scientist and Research Operations positions. She moved on to significant roles in financial and research operations, particularly in leadership positions at Alexion Pharmaceuticals, Inc., and Vion Pharmaceuticals.
Karen Guarco's Role at Alexion Pharmaceuticals
At Alexion Pharmaceuticals, Karen Guarco held several leadership roles including Senior Director of Financial Planning & Analysis, and Global R&D Controller. She led a global finance team, managing all aspects of R&D financial management, long-range strategic planning, and process improvement. Her responsibilities extended to overseeing acquisitions and striving for operational excellence. Her work at Alexion highlighted her ability to drive financial stability and strategic growth within the company.
Karen Guarco's Consulting Experience
Karen Guarco has worked as an R&D and Financial consultant for both startup biotech firms and established pharmaceutical companies. Her consulting role allowed her to apply her extensive knowledge of drug discovery and finance to help these companies navigate financial and operational challenges. Her strategic insight and practical experience have been pivotal in supporting clients through complex business environments.
Karen Guarco's Education
Karen Guarco earned a BSc in Pathobiology from the University of Connecticut, providing her with a strong foundation in scientific research. She furthered her expertise by obtaining an MBA in Finance from the University of New Haven, which equipped her with critical skills in financial planning and management. This combination of scientific and financial education has been instrumental in her successful career in the pharmaceutical industry.